title: The Parma international randomized study in relapsed non Hodgkin lymphoma: 1st interim analysis of 128 patients (as 15 January 1991: 153 patients).
authors.affiliation: Centre Leon Bérard, Lyon, France.
authors.forename: A
authors.initials: A
authors.lastname: Hagenbeek
authors.forename: T
authors.initials: T
authors.lastname: Philip
authors.forename: D
authors.initials: D
authors.lastname: Bron
authors.forename: C
authors.initials: C
authors.lastname: Guglielmi
authors.forename: B
authors.initials: B
authors.lastname: Coiffier
authors.forename: C
authors.initials: C
authors.lastname: Gisselbrecht
authors.forename: J C
authors.initials: JC
authors.lastname: Kluin Nelemans
authors.forename: R
authors.initials: R
authors.lastname: Somers
authors.forename: J L
authors.initials: JL
authors.lastname: Misset
authors.forename: J
authors.initials: J
authors.lastname: Van der Lely
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002330:Carmustine / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D008875:Middle Aged; D012074:Remission Induction; D014182:Transplantation, Autologous
chemical_list: D003561:Cytarabine; D005047:Etoposide; D003907:Dexamethasone; D003520:Cyclophosphamide; D002945:Cisplatin; D002330:Carmustine